Acute coronary syndromes in young lupus patients, shifting the view on the old problem

Sofia Ajeganova1

  • 1Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. sofia.ajeganova@ki.se.

Insights

Younger patients with systemic lupus erythematosus (SLE) face a high risk of acute myocardial infarction (AMI), despite traditional tools not identifying them as high-risk. This review highlights unique cardiovascular disease (CVD) challenges in this population.

Area of Science:

  • Rheumatology
  • Cardiology
  • Internal Medicine

Background:

  • Systemic lupus erythematosus (SLE) patients have elevated coronary heart disease (CHD) risk.
  • Younger female SLE patients are disproportionately affected by acute myocardial infarction (AMI), often undetected by standard risk assessments.
  • Traditional cardiovascular disease (CVD) risk factors and subclinical atherosclerosis are less prevalent in young SLE patients experiencing AMI.

Purpose of the Study:

  • To increase awareness of the link between SLE and CVD in younger individuals.
  • To explore non-atherosclerotic mechanisms contributing to CHD in SLE patients.
  • To discuss unique acute coronary syndromes (ACS) in young SLE patients and challenges in risk identification.

Main Methods:

  • A narrative review of selected articles focusing on SLE and cardiovascular events in younger patients.
  • Analysis of existing literature to identify gaps in research and clinical practice.
  • Synthesis of current understanding regarding CVD mechanisms and management in young SLE patients.

Main Results:

  • Young SLE patients experience AMI without significant coronary artery obstruction, differing from older populations.
  • A decline in ACS and AMI incidence seen in the general population has not mirrored in younger SLE patients.
  • Current cardiac screening guidelines are lacking for young SLE patients, particularly those with non-specific symptoms.

Conclusions:

  • There is a critical need for heightened awareness and research into CVD in young SLE patients.
  • Individualized treatment strategies and advanced imaging techniques are essential for managing ACS in this population.
  • Understanding unique CVD pathways in young SLE patients is crucial for improving outcomes and developing targeted interventions.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
294